
BioEnvelop Technologies Corporation — Investor Relations & Filings
BioEnvelop Technologies Corporation specialized in the research, development, and manufacturing of innovative bio-based materials, primarily focusing on advanced oral delivery systems. The company's core offering was a rapidly dissolving edible film strip technology utilized by the nutraceutical and pharmaceutical sectors. This platform enabled the production of thin-film formats for nutritional supplements and supergeneric drugs, providing a unique, efficient delivery mechanism. The company entered into exclusive manufacturing agreements with contract manufacturers and pharmaceutical firms to leverage this technology. BioEnvelop's assets and intellectual property were acquired by specialty pharmaceutical firm Paladin Labs Inc. in 2007.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Material change report - English.PDF | 2006-05-31 | English | |
| Material change report - English.PDF | 2006-03-09 | English | |
| Material change report - English.PDF | 2005-07-08 | English | |
| Material change report - English.PDF | 2005-05-18 | English | |
| Material change report - English.PDF | 2004-12-09 | English | |
| Material change report - English.pdf | 2003-12-23 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2006
2 filings
| |||||
| 47638991 | Material change report - English.PDF | 2006-05-31 | English | ||
| 47638995 | Material change report - English.PDF | 2006-03-09 | English | ||
|
2005
2 filings
| |||||
| 47638999 | Material change report - English.PDF | 2005-07-08 | English | ||
| 47639067 | Material change report - English.PDF | 2005-05-18 | English | ||
|
2004
1 filing
| |||||
| 47639071 | Material change report - English.PDF | 2004-12-09 | English | ||
|
2003
1 filing
| |||||
| 47639075 | Material change report - English.pdf | 2003-12-23 | English | ||
|
2002
5 filings
| |||||
| 47639084 | Material change report - English.pdf | 2002-12-10 | English | ||
| 47639088 | Material change report - English.pdf | 2002-08-01 | English | ||
| 47639091 | Other.pdf | 2002-01-03 | English | ||
| 47639096 | Other.pdf | 2002-01-03 | English | ||
| 47639100 | Other.pdf | 2002-01-03 | English | ||
|
2001
4 filings
| |||||
| 47639104 | Other.pdf | 2001-08-15 | English | ||
| 47639131 | Decision Document (Final).pdf | 2001-08-01 | English | ||
| 47639259 | Consent letter of underwriters' legal counsel.pdf | 2001-07-31 | English | ||
| 47639268 | Other.pdf | 2001-07-31 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
OCULAR THERAPEUTIX, INC
Biopharmaceutical company developing sustained-release ther…
|
OCUL | US | Manufacturing |
|
Oculis Holding AG
Clinical-stage biopharma developing therapies for ophthalmi…
|
OCS | CH | Manufacturing |
|
Ocumension Therapeutics
Ophthalmic pharmaceutical platform dedicated to R&D and com…
|
1477 | KY | Manufacturing |
|
ODI Pharma AB
Produces and distributes regulated medicinal cannabis for t…
|
ODI | SE | Manufacturing |
|
OKYO Pharma Ltd
Clinical-stage biopharma developing drugs for eye diseases …
|
OKYO | US | Manufacturing |
|
Olema Pharmaceuticals, Inc.
A clinical-stage biopharma developing targeted therapies fo…
|
OLMA | US | Manufacturing |
|
OliX Pharmaceuticals, Inc.
Clinical-stage company developing RNAi therapeutics for der…
|
226950 | KR | Manufacturing |
|
OMEROS CORP
Develops small-molecule and protein therapeutics for unmet …
|
OMER | US | Manufacturing |
|
Omkar Pharmachem Ltd.
Manufacturer and distributor of APIs, chemical intermediate…
|
532167 | IN | Manufacturing |
|
Oncodesign Precision Medicine S.A
Develops therapeutic and diagnostic solutions for resistant…
|
ALOPM | FR | Manufacturing |
BioEnvelop Technologies Corporation via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/44781/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=44781 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=44781 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=44781 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 44781}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BioEnvelop Technologies Corporation (id: 44781)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.